» Articles » PMID: 9162350

[Role of Expectant Therapy in Prostatic Carcinoma of Low Grade and Staging]

Overview
Publisher PagePress
Date 1996 Dec 1
PMID 9162350
Authors
Affiliations
Soon will be listed here.
Abstract

Low stage and grade prostate cancer can be treated by radical prostatectomy, radiotherapy and expectant therapy. Preoperative evaluation with biopsy is in many cases unreliable to pathological stage and grade. In this study we considered 31 patients with prostate cancer, evaluated with directed ultrasound guided biopsy (15) or with sextant biopsy (16). Sextant biopsy showed better results. Grading was confirmed by radical prostatectomy specimen in 62.5%. The role of expectant therapy is then discussed.